- Home
- HUBB vs TEVA Comparison
HUBB vs TEVA Comparison
Compare HUBB & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBB
- TEVA
- Stock Information
- Founded
- HUBB 1888
- TEVA 1901
- Country
- HUBB United States
- TEVA Israel
- Employees
- HUBB N/A
- TEVA N/A
- Industry
- HUBB Industrial Machinery/Components
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- HUBB Technology
- TEVA Health Care
- Exchange
- HUBB Nasdaq
- TEVA Nasdaq
- Market Cap
- HUBB 19.0B
- TEVA 18.4B
- IPO Year
- HUBB N/A
- TEVA N/A
- Fundamental
- Price
- HUBB $338.97
- TEVA $13.65
- Analyst Decision
- HUBB Hold
- TEVA Strong Buy
- Analyst Count
- HUBB 8
- TEVA 6
- Target Price
- HUBB $449.38
- TEVA $24.00
- AVG Volume (30 Days)
- HUBB 758.2K
- TEVA 12.0M
- Earning Date
- HUBB 05-01-2025
- TEVA 05-07-2025
- Dividend Yield
- HUBB 1.56%
- TEVA N/A
- EPS Growth
- HUBB 2.28
- TEVA N/A
- EPS
- HUBB 14.37
- TEVA N/A
- Revenue
- HUBB $5,628,500,000.00
- TEVA $16,544,000,000.00
- Revenue This Year
- HUBB $6.26
- TEVA $5.31
- Revenue Next Year
- HUBB $5.43
- TEVA $1.18
- P/E Ratio
- HUBB $23.59
- TEVA N/A
- Revenue Growth
- HUBB 4.76
- TEVA 4.41
- 52 Week Low
- HUBB $299.43
- TEVA $12.47
- 52 Week High
- HUBB $481.35
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- HUBB 47.46
- TEVA 37.96
- Support Level
- HUBB $334.20
- TEVA $13.24
- Resistance Level
- HUBB $360.11
- TEVA $13.83
- Average True Range (ATR)
- HUBB 17.25
- TEVA 0.80
- MACD
- HUBB 2.82
- TEVA -0.03
- Stochastic Oscillator
- HUBB 65.16
- TEVA 38.44
About HUBB Hubbell Inc
Hubbell is a diversified conglomerate industrial company that mostly competes in the electrical components market. Its products and services serve vital portions of the U.S. electrical supply chain, including transmission and distribution as well as the commercial, industrial, and residential end markets. The company organizes its business into two segments: Utility Solutions Segment and the Electrical Solutions Segment. It derives maximum revenue from Utility Solutions Segment.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.